– USA, MI – Zomedica Pharmaceuticals Corp. (NYSE: ZOM | TSX: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that Johnny D. Powers has been appointed to its board of directors as an independent director. Additionally, Powers will also serve as a member of the audit, compensation, and corporate governance committees of the board of directors.
“We are pleased that a person of Johnny’s stature and reputation in the animal health industry has agreed to join our Board of Directors and we look forward to utilizing his expertise and experience as we complete the development and begin the commercialization of our product candidates,” said Gerald Solensky Jr., Chairman and CEO, Zomedica.
About Dr Johnny Powers
Powers has more than 30 years of experience leading business strategy, operations, sales and marketing, and product development in the human and pet medical diagnostics markets. Notably, he held executive roles at animal health industry leader IDEXX Laboratories, Inc., where, prior to his retirement, he served as executive vice president responsible for business performance, product innovation and commercial effectiveness across multiple point-of-care and reference laboratory businesses. Currently, Powers is the president and founder of JD Powers Consulting Group, which provides strategic and executive advisory services in the healthcare industry.
“I am excited to be joining Zomedica’s board of directors,” said Johnny D. Powers. “I look forward to helping Zomedica achieve its goal of delivering novel diagnostic and therapeutic solutions to the companion animal market that improve diagnosis and treatment, lower costs, and enhance outcomes for pet owners and their animals.”
Dr. Powers holds a bachelor’s degree in chemistry from Wake Forest University, an M.S. in chemical engineering from Clemson University, an M.B.A. from the Duke University Fuqua School of Business and a Ph.D. in biochemical engineering from North Carolina State University.
Based in Ann Arbor, Michigan, Zomedica is a veterinary diagnostic and pharmaceutical company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care.
For more information: https://www.zomedica.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.